Zobrazeno 1 - 10
of 1 281
pro vyhledávání: '"J. Tiihonen"'
Autor:
J.S. Toimela, A.H. Halt, M. Kerkelä, O. Kampman, J. Suvisaari, T. Kieseppä, M. Lähteenvuo, J. Tiihonen, A. Ahola-Olli, J. Veijola, M. Holm
Publikováno v:
Schizophrenia Research: Cognition, Vol 37, Iss , Pp 100316- (2024)
Background: Both overweight and cognitive deficits are common among people with schizophrenia (SZ) and schizoaffective disorder. The results in earlier studies have been inconsistent on whether overweight is associated with cognitive deficits in psyc
Externí odkaz:
https://doaj.org/article/d88a5f2090614101b96c9ab691e6ccc8
Publikováno v:
European Psychiatry, Vol 66, Pp S253-S254 (2023)
Introduction Antidepressants are often used by persons with schizophrenia. These medications are used for a variety of symptoms, such as negative or depressive ones. Effectiveness of antidepressant use in persons with schizophrenia has rarely been st
Externí odkaz:
https://doaj.org/article/9789ac9fc86648df94b8c3f87d344678
Publikováno v:
European Psychiatry, Vol 66, Pp S442-S442 (2023)
Introduction Depression markedly increases the risk of suicide, and depression is the most common psychiatric disorder diagnosed in persons with a completed suicide, but the interplay between depression and psychotic symptoms in suicides has remained
Externí odkaz:
https://doaj.org/article/eabb5dc0df2f474e84ff54775a853984
Autor:
C. Okhuijsen-Pfeifer, M. Z. van der Horst, C. A. Bousman, B. Lin, K. R. van Eijk, S. Ripke, Y. Ayhan, M. O. Babaoglu, M. Bak, W. Alink, H. van Beek, E. Beld, A. Bouhuis, M. Edlinger, I. M. Erdogan, A. Ertuğrul, G. Yoca, I. P. Everall, T. Görlitz, GROUP (Genetic Risk and Outcome of Psychosis) investigators, K. P. Grootens, S. Gutwinski, T. Hallikainen, E. Jeger-Land, M. de Koning, M. Lähteenvuo, S. E. Legge, S. Leucht, C. Morgenroth, A. Müderrisoğlu, A. Narang, C. Pantelis, A. F. Pardiñas, T. Oviedo-Salcedo, J. Schneider-Thoma, S. Schreiter, E. Repo-Tiihonen, H. Tuppurainen, M. Veereschild, S. Veerman, M. de Vos, E. Wagner, D. Cohen, J. P. A. M. Bogers, J. T. R. Walters, A. E. Anil Yağcıoğlu, J. Tiihonen, A. Hasan, J. J. Luykx
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Clozapine is the most effective antipsychotic for patients with treatment-resistant schizophrenia. However, response is highly variable and possible genetic underpinnings of this variability remain unknown. Here, we performed polygenic risk
Externí odkaz:
https://doaj.org/article/336ada6c3f194f2c90127be5920de5e1
Publikováno v:
European Psychiatry, Vol 65, Pp S268-S268 (2022)
Introduction Due to its relatively high prevalence and recurrent nature, depression causes a major burden on healthcare systems and societies. Objectives To investigate healthcare resource utilization and costs associated with treatment-resistant de
Externí odkaz:
https://doaj.org/article/e2bf043b450a43f9894e5ce132344dfd
Publikováno v:
European Psychiatry, Vol 64, Pp S108-S108 (2021)
Introduction There is a lack of knowledge on utilized pharmacotherapies for treatment resistant depression (TRD). Objectives To investigate the courses of treatment of TRD. Methods All patients aged 16-65 years and diagnosed with depression in Fi
Externí odkaz:
https://doaj.org/article/8218dd513f4b46fc84bc5f488b2d1ebe
Autor:
M. Lähteenvuo, J. Luykx, H. Taipale, E. Mittendorfer-Rutz, A. Tanskanen, A. Batalla, J. Tiihonen
Publikováno v:
European Psychiatry, Vol 64, Pp S161-S161 (2021)
Introduction Schizophrenia is highly comorbid with substance use disorders (SUD), which may negatively impact the course of illness. However, large studies exploring the best lines of treatment for this combination are lacking. Objectives We invest
Externí odkaz:
https://doaj.org/article/3ee02bb41d4946a280754ba5126f59aa
Morbidity and mortality in schizophrenia with comorbid substance use disorders in Finland and Sweden
Autor:
M. Lähteenvuo, A. Batalla, J. Luykx, E. Mittendorfer-Rutz, A. Tanskanen, J. Tiihonen, H. Taipale
Publikováno v:
European Psychiatry, Vol 64, Pp S237-S238 (2021)
Introduction Schizophrenia is highly comorbid with substance use disorders (SUD) but large epidemiological cohorts exploring the prevalence and prognostic significance of SUD are lacking. Objectives To investigate the prevalence of SUD in patients
Externí odkaz:
https://doaj.org/article/2e6b30ac4f5c4028abfcfe2009d81cac
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background In several countries, immigrants have higher disability pension (DP) rates than natives. Reasons for this are poorly understood. The aim of this study was to investigate if the risk of diagnosis-specific DP differed in first, seco
Externí odkaz:
https://doaj.org/article/7390859af8d740e884ffe657bf24365c
Publikováno v:
European Neuropsychopharmacology. 61:36-42
The aim of the study was to compare the real-world effectiveness of mood stabilizers and antipsychotics in the prevention of psychiatric hospitalizations and treatment failure after lithium discontinuation in a nationwide bipolar cohort. Using health